// App-Quantinova.ai

1767 ⋆ : NK cells in the ascites of patients with advanced liver cirrhosis are phenotypically distinct from blood and liver NK cells and may be involved in antibacterial defense

Researchers

Presenter

  • Philipp Lutz

Principal Investigators

  • Hannah C. Jeffery

  • Nicholas Jones

  • Jane Birtwistle

  • Jacob Nattermann

  • Ulrich Spengler

  • Christian P. Strassburg

  • David H. Adams

  • Ye H. Oo

Medical Centers

  • Internal Medicine I, University of Cologne, Cologne, Germany

  • Centre for Liver Research and National Institute of Health Research Liver Biomedical Research Unit Birmingham, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom

  • Institute of LSwansea University Medical School, University of Swansea, Swansea, United Kingdom

  • University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom

  • Human Biomaterial Resource Centre, University of Birmingham, Birmingham, United Kingdom

Locations

  • Germany

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Gastroenterology (GU)

Disease

  • Cirrhosis

Biomarkers

  • Natural Killer cells

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A